Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
– Advancing Phase 2 clinical trials of verekitug in patients with severe asthma and CRSwNP – – Commenced startup for a Phase 2 clinical trial in COPD; on track for first patient to be dosed in H2...
WALTHAM, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus...
WALTHAM, Mass., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -8.01 | -30.7840122982 | 26.02 | 26.7 | 17.8101 | 285787 | 22.20943714 | CS |
| 4 | -7.015 | -28.031968032 | 25.025 | 29.35 | 17.8101 | 248101 | 24.75725924 | CS |
| 12 | -3.49 | -16.2325581395 | 21.5 | 29.35 | 17.8101 | 350576 | 24.21355152 | CS |
| 26 | -3.49 | -16.2325581395 | 21.5 | 29.35 | 17.8101 | 350576 | 24.21355152 | CS |
| 52 | -3.49 | -16.2325581395 | 21.5 | 29.35 | 17.8101 | 350576 | 24.21355152 | CS |
| 156 | -3.49 | -16.2325581395 | 21.5 | 29.35 | 17.8101 | 350576 | 24.21355152 | CS |
| 260 | -3.49 | -16.2325581395 | 21.5 | 29.35 | 17.8101 | 350576 | 24.21355152 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Premium
